Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo

Journal of Orthopaedic Research

Volumn 32, Issue 6, 2014, Pages 744-751

  Fu, Yangmu ^a   Zhang, Qiang ^a   Sun, Yong ^a   Liao, Weixiong ^a   Bai, Xiaowei ^a   Zhang, Lili ^a   Du, Lina ^b   Jin, Yiguang ^b   Wang, Qi ^c   Li, Zhongli ^a   Wang, Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c Affiliated Hospital of Logistics College of Chinese Peoples Armed Police Force   (China)

Author keywords

bone growth; microsphere; rhBMP 2; Ti6Al4V; butyl cyanoacrylate

Indexed keywords

ACID; ALPHA BUTYL CYANOACRYLATE; ENBUCRILATE; MICROSPHERE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE IMPLANT; BONE REGENERATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HISTOLOGY; IMPLANTATION; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEAR STRENGTH; SURFACE PROPERTY;

BONE GROWTH; MICROSPHERE; RHBMP-2; TI6AL4V; Α-BUTYL CYANOACRYLATE;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEIN 2; COATED MATERIALS, BIOCOMPATIBLE; ENBUCRILATE; HUMANS; IMPLANTS, EXPERIMENTAL; MICROSPHERES; OSSEOINTEGRATION; RABBITS; RECOMBINANT PROTEINS; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897998460     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22594     Document Type: Article

References (37)

1. Long M, Rack HJ., 1998. Titanium alloys in total joint replacement-a materials science perspective. Biomaterials 19: 1621-1639.
2. Taki N, Tatro JM, Nalepka JL, et al. 2005. Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 23: 376-383.
3. Bi Y, Van De Motter RR, Ragab AA, et al. 2001. Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Joint Surg 83A: 501-508.
4. Greenfield EM, Bi Y, Ragab AA, et al. 2002. The role of osteoclast differentiation in aseptic loosening. J Orthop Res 20: 1-8.
5. Bi Y, Collier TO, Goldberg VM, et al. 2002. Adherent endotoxin mediates biological responses of titanium particles without stimulating their phagocytosis. J Orthop Res 20: 696-703.
6. Zareidoost A, Yousefpour M, Ghaseme B, et al. 2012. The relationship of surface roughness and cell response of chemical surface modification of titanium. J Mater Med 23: 1479-1488.
7. Traini T, Assenza B, San Roman F, et al. 2006. Bone microvascular pattern around loaded dental implants in a canine model. Clin Oral Investig 10: 151-156.
8. Schwarz F, Herten M, Sager M, et al. 2007. Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA titanium implants. A pilot study in dogs. Clin Oral Investig 11: 245-255.
9. Mangano C, Perrotti V, Iezzi G, et al. 2008. Bone response to modified titanium surface implants in nonhuman primates (Papio ursinus) and humans: histological evaluation. J Oral Implantol 34: 17-24.
10. Degidi M, Artese L, Piattelli A, et al. 2012. Histological and immunohistochemical evaluation of the peri-implant soft tissues around machined and acid-etched titanium healing abutments: a prospective randomised study. Clin Oral Investig 16: 857-866.
11. Bobyn JD, Pilliar RM., 1980. The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone. Clin Orthop 150: 263-270.
12. Takaoka K, Yoshikawa H, Hasimoto J, et al. 1993. Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosarcoma. Clin Orthop Relat Res 294: 344-352.
13. Takaoka K, Yoshikawa H, Hashimoto J, et al. 1993. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type). Clin Orthop Relat Res 292: 329-336.
14. Wozney JM, Rosen V, Celeste AJ, et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
15. Wang EA, Rosen V, D'Alessandro JS, et al. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220.
16. Namikawa T, Terai H, Hoshino M, et al. 2007. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine (Phila Pa 1976) 32: 2294.
17. Namikawa T, Terai H, Suzuki E, et al. 2005. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine (Phila Pa 1976) 30: 1717.
18. Boden SD, Kang J, Sandhu H, et al. 2002. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) 27: 2662.
19. Lee JK, Cho LR, Um HS, et al. 2013. Bone formation and remodeling of three different dental implant surfaces with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in a rabbit model. Int J Oral Maxillofac Implants 28: 424-4430.
20. Park JC, Lee JB, Daculsi G, et al. 2012. Novel analysis model for implant osseointegration using ectopic bone formation via the recombinant human bone morphogenetic protein-2/macroporous biphasic calcium phosphate block system in rats: a proof-of-concept study. J Periodontal Implant Sci 42: 136-143.
21. Choi H, Park NJ, Jamiyandorj O, et al. 2012. Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2. Periodontal Implant Sci 42: 119-126.
22. McClellan JW, Mulconrey DS, Forbes RJ, et al. 2006. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 19: 483.
23. Xiao W, Fu H, Rahaman MN, et al. 2013. Hollow hydroxyapatite microspheres: a novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration. Acta Biomater 9: 8374-8383.
24. Zhao YP, Tian QY, Frenkel S, et al. 2013. The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling. Biomaterials 34: 6412-6421.
25. Liu T, Wu G, Wismeijer D, et al. 2013. Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep. Bone 56: 110-118.
26. Lee JH, Ryu MY, Baek HR, et al. 2013. Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration. J Mater Sci Mater Med 24: 2117-2127.
27. Fu Y, Du L, Wang Q, et al. 2012. In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels. Pharmazie 67: 299-303.
28. Linden CL Jr, Shalaby SW., 1997. Performance of modified cyanoacrylate composition as tissue adhesives for soft and hard tissues. J Biomed Mater Res (Appl Biomater) 38: 348-355.
29. Pawar RP, Sarda SR, Borade RM, et al. 2008. Cyano acrylate polymers in medical applications. Recent Patents Mater Sci 1: 186-199.
30. Ballo AM, Xia W, Palmquist A, et al. 2012. Bone tissue reactions to biomimetic ion-substituted apatite surfaces on titanium implants. J R Soc Interface 9: 1615-1624.
31. Fukunaga K, Minoda Y, Iwakiri K, et al. 2012. Early biological fixation of porous implant coated with paste-retaining recombinant bone morphogenetic protein 2. J Arthroplasty 27: 143-149.
32. Berry D, Harmsen W, Cabanela M, et al. 2002. Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg 84: 171-177.
33. Sundfeldt M, Carlsson LV, Johansson CB, et al. 2006. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 77: 177-197.
34. Schmalzried TP, Jasty M, Harris WH., 1992. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg 74: 849-863.
35. Teixeira LN, Crippa GE, Lefebvre L-P, et al. 2012. The influence of pore size on osteoblast phenotype expression in cultures grown on porous titanium. Int J Oral Maxillofac Surg 41: 1097-1101.
36. Lee SS, Huang BJ, Kaltz SR, et al. 2013. Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. Biomaterials 34: 452-459.
37. de Guzman RC, Saul JM, Ellenburg MD, et al. 2013. Bone regeneration with BMP-2 delivered from keratose scaffolds. Biomaterials 34: 1644-1656.